focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

4 Feb 2020 07:00

RNS Number : 8743B
GLI Finance Limited
04 February 2020
 

4 February 2020

GLI Finance Limited (the "Group")Trading Update

GLI Finance today announces a trading update.

Sancus BMS 

The Group's core business, Sancus BMS Group Limited ("Sancus BMS"), continues to grow, with its asset backed loan book increasing 19% to £199m for the year ended 31 December 2019 ("FY19"). The growth of Sancus UK has been below expectations, but the Group expects further traction in 2020 as this relatively new business becomes more established.

Whilst the financial results are still subject to audit, Sancus BMS is expected to generate revenue of approximately £13m for FY19 (31 December 2018: £13.3m). Loan book growth did not translate to revenue growth, largely due to the Group's strategy, as previously announced, to sell down its on-balance sheet loan exposure in order to use cash assets to repay or buy back its ZDP shares, thus reducing the Group's interest income.

The Group expects to have delivered a further £1m in cost savings for FY19 due to a reduction in headcount (from 42 to 34 staff), largely from the closure of the Sancus Finance business in the UK, and from efficiencies associated with the roll out of Sancus' proprietary lending platform which launched in 2018.

As the impact of the reduction in interest income and slower than expected growth of Sancus UK outweighed the Group's cost savings, the Group expects to record a net operating loss for FY19, however the outcome is highly contingent on a proposed refinancing of a development loan, upon which the Company had previously made a provision of £1.5 million. Discussions in relation to the refinancing of the loan are progressing and, if they are successfully concluded before finalisation of the Group's audited accounts for FY19, the Group expects to release the provision and deliver a net operating profit for FY19.

More broadly, the Group remains focussed on the core asset backed lending offering across the six jurisdictions in which it operates. Sancus BMS surpassed the £1 billion total lending milestone in 2019 and, with a very strong pipeline and a proprietary electronic platform, the business is well placed to build on this and take advantage of the significant growth potential in the UK and Ireland in 2020 and beyond.

FinTech Ventures 

The Group announces that it expects a further write down in the valuation of its FinTech Ventures portfolio for FY19. Whilst still subject to audit review, the expected quantum of the write down is expected to be material. The write down relates to some portfolio companies which have failed to achieve profitability as quickly as previously anticipated and are seeking to raise further equity capital.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014.

GLI Finance

+44 (0)1534 708900

Andy Whelan

Nominated Adviser and Broker

Liberum Capital Limited

+44 (0)203 100 2000

Chris ClarkeEdward Thomas

Public Relations Adviser

Instinctif Partners

+44 (0)207 457 2020

Tim Linacre

Katie Bairsto

LEI: 213800S2XOO3YSEGCA26

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSFSMLESSELE
Date   Source Headline
23rd Sep 20147:00 amRNSHalf Yearly Report
19th Sep 20142:55 pmRNSSharedealing
17th Sep 20147:00 amRNSAdditional Listing
16th Sep 20147:00 amRNSEmma Stubbs appointment
5th Sep 20147:00 amRNSNotice of Results
18th Aug 20147:00 amRNSNAV and Trading Update
16th Jul 20147:00 amRNS2014 Second Interim Dividend
20th Jun 20145:25 pmRNSHolding(s) in Company
20th Jun 20147:00 amRNSDirector/PDMR Shareholding
19th Jun 20147:00 amRNSAdditional Listing
12th Jun 20147:00 amRNSDisposal of CLO investments
19th May 20147:00 amRNSAgreement to Dispose of CLO investments
6th May 20147:01 amRNSDirector/PDMR Shareholding
2nd May 20145:00 pmRNSDirector/PDMR Shareholding
30th Apr 20144:56 pmRNSResult of AGM
30th Apr 20147:00 amRNSAGM Statement
24th Apr 20147:00 amRNSDividend Declaration
24th Apr 20147:00 amRNSNet Asset Value(s)
4th Apr 20143:16 pmRNSAnnual Financial Report
26th Mar 20147:00 amRNSFinal Results
24th Mar 20147:00 amRNSNotice of Results
20th Mar 20141:48 pmRNSDirector/PDMR Shareholding
19th Mar 201412:51 pmRNSAdditional Listing
6th Mar 20147:00 amRNS2013 Fourth Interim Dividend - Timetable amendment
26th Feb 201412:11 pmRNSHolding(s) in Company
19th Feb 20141:29 pmRNSHolding(s) in Company
29th Jan 201411:34 amRNSHolding(s) in Company
24th Jan 20144:45 pmRNSDirector/PDMR Shareholding
24th Jan 201412:00 pmRNSDirector/PDMR Shareholding
22nd Jan 201412:10 pmRNSDirector/PDMR Shareholding
22nd Jan 20147:00 amRNSNAV and Trading Update
21st Jan 20147:00 amRNSDividend Declaration
9th Dec 201312:46 pmRNSCancellation of listing from CISX
5th Dec 201311:30 amRNSResult of EGM
5th Dec 20138:00 amRNSDirector/PDMR Shareholding
4th Dec 20133:00 pmRNSSCRIP DIVIDEND - ADDITIONAL LISTING
13th Nov 201311:00 amRNSInvesting policy / Cancellation CISX listing / EGM
6th Nov 201311:00 amRNSHolding(s) in Company
4th Nov 20132:00 pmRNSHolding(s) in Company
29th Oct 20134:30 pmRNSHolding(s) in Company
29th Oct 20134:00 pmRNSChange of Adviser
24th Oct 20137:00 amRNSNAV and Trading Update
21st Oct 201312:45 pmRNSResult of EGM
9th Oct 20137:00 amRNSDividend Declaration
3rd Oct 201311:30 amRNSPublication of circular and General Meeting
1st Oct 20137:00 amRNSResults of Placing
30th Sep 20138:01 amRNSIssue of Equity
30th Sep 20137:00 amRNSInterim Results
24th Sep 20132:00 pmRNSHolding(s) in Company
19th Sep 20133:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.